Atila HCV Assay Kit

The Atila HCV Assay Kit is a reverse transcription polymerase chain reaction (RT-PCR) assay based on a proprietary technology developed to improve the efficiency of detecting multiple viral nucleic acid targets simultaneously by reducing non-specific interactions and amplifications.

DNA oligos are designed to specifically detect and discriminate HCV RNA. The assay does not discriminate the HCV genotypes. The test also includes an Internal Control (IC) for monitoring test performance in each individual test.

The Atila HCV Assay Kit is intended for use by qualified and trained laboratory personnel specifically instructed and trained in the techniques of real-time nucleic acid amplification and in vitro diagnostic procedures.

Hepatitis C virus (HCV) is a single-stranded RNA virus, with a genome size of approximately 9500 nucleotides. HCV can cause Hepatitis C, a liver disease, and is a major cause of liver cancer. The virus causes both acute and chronic hepatitis. Around 30% (15–45%) of infected persons spontaneously clear the virus within 6 months of infection without any treatment.

However, the remaining 70% (55–85%) of persons will develop chronic HCV infection. Of those with chronic HCV infection, the risk of cirrhosis ranges between 15% and 30% within 20 years. The HCV is a bloodborne virus, is transmitted by sharing injection equipment, transfusion or exposure to the infected blood, and can also be transmitted sextually or from infected mother to baby.